0000899243-22-021888.txt : 20220610
0000899243-22-021888.hdr.sgml : 20220610
20220610160522
ACCESSION NUMBER: 0000899243-22-021888
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220609
FILED AS OF DATE: 20220610
DATE AS OF CHANGE: 20220610
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cheng Isaac
CENTRAL INDEX KEY: 0001829696
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41199
FILM NUMBER: 221008844
MAIL ADDRESS:
STREET 1: C/O ATEA PHARMACEUTICALS, INC.
STREET 2: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Amylyx Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001658551
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 464600503
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 43 THORNDIKE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
BUSINESS PHONE: 617-683-0917
MAIL ADDRESS:
STREET 1: 43 THORNDIKE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-09
0
0001658551
Amylyx Pharmaceuticals, Inc.
AMLX
0001829696
Cheng Isaac
C/O AMYLYX PHARMACEUTICALS, INC.
43 THORNDIKE STREET
CAMBRIDGE
MA
02142
1
0
0
0
Stock Option (Right to Buy)
13.56
2022-06-09
4
A
0
19000
0.00
A
2032-06-09
Common Stock
19000
19000
D
This option shall vest in full upon the earlier of (i) June 9, 2023 or (ii) the date of the next annual meeting, all vesting shall cease if the director resigns from the Board or otherwise ceases to service as a director.
/s/ Joshua B. Cohen, as Attorney-in-Fact
2022-06-10